Stock listing

Lang & Schwarz:A3CRZT Carvolix Aktie

German listing (Lang & Schwarz) of Carvolix · home listing Euronext:CVX

Follow Carvolix into a list and get an email when it puts out news.

Home listing price · EURONEXT:CVX

€6.00 EUR +0.74 (+14.1%)

Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:CVX

Since Jul 6, 2026 +36.4% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
€4.92 – €6.00 EUROct 19, 2026
Volume
67,293 sharesOct 19, 2026
Market value
€373.4M EURAt the close on Oct 19, 2026 · price × 62.23M shares outstanding
Carvolix logo
Ticker
Lang & Schwarz:A3CRZT
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Latest news

Nombre d’actions composant le capital social et nombre total de droits de vote au 30.09.26

Oct 8, 2026

Carvolix Appoints Anne Lange as Chair of its Board of Directors Confirming the Acceleration of its Ambitions and Reports 2026 Half-Year Results.

Sep 30, 2026

Carvolix nomme Anne Lange à la présidence de son Conseil d'administration et publie ses résultats semestriels 2026, confirmant l'accélération de ses ambitions.

Sep 30, 2026

Carvolix submits 510(k) for TAVIPILOT Robot, advancing toward US commercial launch of Its Integrated TAVIPILOT Platform.

Sep 22, 2026

Carvolix Takes a Key Step Toward Commercial Launch of TAVIPILOT Software in Europe with Regulatory Submission for CE Marking.

Sep 9, 2026

Carvolix Secures EUR 30 Million Of Structured Debt Financing To Fuel Its Growth.

Aug 6, 2026

Carvolix: ODDO BHF initiates coverage of Carvolix with an Outperform rating.

Jul 29, 2026

Carvolix presents promising clinical data on the TAVIPILOT platform at New York Valves 2026

Jul 6, 2026

Carvolix Secures New EUR 10m Tranche, Bringing Total Financing to EUR 20m as Part of its EUR 30m Programme

Jun 24, 2026

Carvolix announces positive 3-years clinical results for Kalios™, the only adjustable mitral ring. 100% of patients met primary endpoint for mitral regurgitation.

Jun 15, 2026

All Carvolix news

Financings

  • Senior secured convertible bonds, amortised bonds and warrants

    Aug 6, 2026 · US$34.59M

    Announced: up to €30M · Warrants at €3.96 for 120 months

    Buyers: Claret Capital Partners (lender; first tranche of EUR 10,000,000 convertible bonds drawn, up to EUR 30 million in total, plus 290,937 warrants issued to CEGCF IV Aggregator L.P. (a Claret entity))

    Use of proceeds: US commercialization of the TAVIPILOT Robotic System and development of Kalios, Artus, Artedrone and Mitrapilot

    Announced Aug 6, 2026

Read by 6ix AI from the company's releases

Decks

Carvolix on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
18 in the last 12 months · 18 in all · newest Oct 8, 2026 · oldest 2025
Decks
3 decks · latest Sep 16, 2026

Where Carvolix is listed

ListingExchangeCountryCurrency
Euronext:CVX · Home listingEuronextFranceEUR
gettex:0JZgettexGermanyEUR
LS Exchange:A3CRZTLS ExchangeGermanyEUR
Lang & Schwarz:A3CRZT · This pageLang & SchwarzGermanyEUR
Aquis:CVXPAquisUnited KingdomEUR
Aquis:CVXPAquisUnited KingdomEUR
Frankfurt:0JZFrankfurtGermanyEUR
Munich:0JZMunichGermanyEUR
Stuttgart:0JZStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Carvolix.